The company's proprietary bioelectronic medicine platform uses a micro-regulator programmed through a unique prescription pad interface. By leveraging the Inflammatory Reflex, SetPoint's therapy offers a safe and cost-effective alternative to drugs, with demonstrated anti-inflammatory potency in animal models. Currently conducting human trials in rheumatoid arthritis, SetPoint aims to provide patients and healthcare providers with an efficacious solution that is more affordable than biologic therapies.